The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.

Saved in:
Bibliographic Details
Title: The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
Authors: Hirabayashi Y; Department of Rheumatology, Hikarigaoka Spellman Hospital, 6-7-1 Higashisendai, Miyagino-ku, Sendai 983-0833, Japan. mr.hirabayashi@gmail.com, Ishii T
Corporate Authors: Michinoku Tocilizumab Study Group
Source: Clinical rheumatology [Clin Rheumatol] 2013 Jan; Vol. 32 (1), pp. 123-7. Date of Electronic Publication: 2012 Oct 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1434-9949
DOI:10.1007/s10067-012-2103-4